Moreover, it has been reported in stroke that the release of interleukine-6 (IL-6), a marker of inflammation, is enhanced by tPA through activation of NMDARs and upregulation of endothelin-1 (ET-1) and c-Jun N-terminal kinase (JNK). This evidence concerns the gene IL6 and stroke disorder.